Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001651308-25-000133
Filing Date
2025-08-06
Accepted
2025-08-06 06:05:46
Documents
97
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bgne-20250630.htm   iXBRL 10-Q 2317615
2 EX-10.18 exhibit10185thamendedandre.htm EX-10.18 62002
3 EX-10.19 exhibit1019beigeneamgensid.htm EX-10.19 28136
4 EX-31.1 exhibit311-2025q2.htm EX-31.1 9852
5 EX-31.2 exhibit312-2025q2.htm EX-31.2 9863
6 EX-32.1 exhibit321-2025q2.htm EX-32.1 6267
12 bgne-20250630_g1.jpg GRAPHIC 1350567
13 image_0a.jpg GRAPHIC 14364
  Complete submission text file 0001651308-25-000133.txt   12870023

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20250630.xsd EX-101.SCH 71249
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bgne-20250630_cal.xml EX-101.CAL 91794
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bgne-20250630_def.xml EX-101.DEF 282435
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20250630_lab.xml EX-101.LAB 733517
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20250630_pre.xml EX-101.PRE 519011
100 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20250630_htm.xml XML 1532944
Mailing Address C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR BASEL Switzerland 4051
Business Address C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR BASEL Switzerland 4051 41-616851900
BeOne Medicines Ltd. (Filer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37686 | Film No.: 251187260
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)